Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

2450. Smith G, Elton RA, Beynon LL,
Newsam JE, Chisholm GD, Hargreave TB
(1983). Prognostic significance of biopsy
results of normal-looking mucosa in cases
of superficial bladder cancer. Br J Urol 55:
665-669.
2451. Smith JR, Freije D, Carpten JD,
Gronberg H, Xu J, Isaacs SD, Brownstein
MJ, Bova GS, Guo H, Bujnovszky P,
Nusskern DR, Damber JE, Bergh A,
Emanuelsson M, Kallioniemi OP, Walker-
Daniels J, Bailey-Wilson JE, Beaty TH,
Meyers DA, Walsh PC, Collins FS, Trent
JM, Isaacs WB (1996). Major susceptibility
locus for prostate cancer on chromosome
1 suggested by a genome-wide search.
Science 274: 1371-1374.
2452. Soejima H, Ogawa O, Nomura Y,
Ogata J (1977). Pheochromocytoma of the
spermatic cord: a case report. J Urol 118:
495-496.
2453. Sogbein SK, Steele AA (1989).
Papillary prostatic epithelial hyperplasia of
the urethra: a cause of hematuria in young
men. J Urol 142: 1218-1220.
2454. Sohn M, Neuerburg J, Teufl F,
Bohndorf K (1990). Gadolinium-enhanced
magnetic resonance imaging in the staging
of urinary bladder neoplasms. Urol Int
45: 142-147.
2455. Sohval AR, Churg J, Gabrilove JL,
Freiberg EK, Katz N (1982). Ultrastructure
of feminizing testicular Leydig cell tumors.
Ultrastruct Pathol 3: 335-345.
2456. Sohval AR, Churg J, Suzuki Y, Katz N,
Gabrilove JL (1977). Electron microscopy
of a feminizing Leydig cell tumor of the
testis. Hum Pathol 8: 621-634.
2457. Soini Y, Turpeenniemi-Hujanen T,
Kamel D, Autio-Harmainen H, Risteli J,
Risteli L, Nuorva K, Paakko P, Vahakangas
K (1993). p53 immunohistochemistry in
transitional cell carcinoma and dysplasia
of the urinary bladder correlates with disease
progression. Br J Cancer 68: 1029-
1035.
2458. Solsona E, Iborra I, Rubio J,
Casanova JL, Ricos JV, Calabuig C (2001).
Prospective validation of the association
of local tumor stage and grade as a predictive
factor for occult lymph node
micrometastasis in patients with penile
carcinoma and clinically negative inguinal
lymph nodes. J Urol 165: 1506-1509.
2459. Solter D (1988). Differential imprinting
and expression of maternal and paternal
genomes. Annu Rev Genet 22: 127-146.
2460. Somers WJ, Terpenning B, Lowe FC,
Romas NA (1988). Renal parenchymal
neurilemoma: a rare and unusual kidney
tumor. J Urol 139: 109-110.
2461. Sommerfeld HJ, Meeker AK,
Piatyszek MA, Bova GS, Shay JW, Coffey
DS (1996). Telomerase activity: a prevalent
marker of malignant human prostate tissue.
Cancer Res 56: 218-222.
2462. Sotelo-Avila C, Beckwith JB,
Johnson JE (1995). Ossifying renal tumor of
infancy: a clinicopathologic study of nine
cases. Pediatr Pathol Lab Med 15: 745-762.
2463. Soulie M, Escourrou G, Vazzoler N,
Seguin P, Suc B, Pontonnier F, Plante P
(2001). [Primary carcinoid tumor and
horseshoe kidney: potential association].
Prog Urol 11: 301-303.
2464. Speicher MR, Schoell B, du Manoir S,
Schrock E, Ried T, Cremer T, Storkel S,
Kovacs A, Kovacs G (1994). Specific loss of
chromosomes 1, 2, 6, 10, 13, 17, and 21 in
chromophobe renal cell carcinomas
revealed by comparative genomic
hybridization. Am J Pathol 145: 356-364.
2465. Speights VOJr, Cohen MK, Riggs
MW, Coffield KS, Keegan G, Arber DA
(1997). Neuroendocrine stains and proliferative
indices of prostatic adenocarcinomas
in transurethral resection samples.
Br J Urol 80: 281-286.
2466. Spencer JR, Brodin AG, Ignatoff JM
(1990). Clear cell adenocarcinoma of the
urethra: evidence for origin within paraurethral
ducts. J Urol 143: 122-125.
2467. Spruck CH3rd, Ohneseit PF,
Gonzalez-Zulueta M, Esrig D, Miyao N,
Tsai YC, Lerner SP, Schmutte C, Yang AS,
Cote R, Dubeau L, Nichols PW, Hermann
GG, Steven K, Horn T, Skinner DG, Jones
PA (1994). Two molecular pathways to
transitional cell carcinoma of the bladder.
Cancer Res 54: 784-788.
2468. Spruck CH3rd, Rideout WM3rd,
Olumi AF, Ohneseit PF, Yang AS, Tsai YC,
Nichols PW, Horn T, Hermann GG, Steven
K, Ross RK, Yu MC, Jones PA (1993).
Distinct pattern of p53 mutations in bladder
cancer: relationship to tobacco
usage. Cancer Res 53: 1162-1166.
2469. Srigley J, Kapusta L, Reuter V, Amin
M, Grignon DJ, Eble JN, Weber A, Moch H
(2002). Phenotypic, molecular and ultrastructural
studies of a novel low-grade
renal epithelial neoplasm possible related
to the loop of Henle. Mod Pathol 15: 182.
2470. Srigley JR, Eble JN (1998). Collecting
duct carcinoma of kidney. Semin Diagn
Pathol 15: 54-67.
2471. Srigley JR, Eble JN, Grignon DJ,
Hartwick RWJ (1999). Unusual renal cell
carcinoma (RCC) with prominent spindle
cell change possibly related to the loop of
Henle. Mod Pathol 12: 107.
2472. Srigley JR, Grignon DJ, Young RH
(2002). The distinction between pure carcinoid
tumor and carcinoid-like adenocarcinoma
of the prostate. Mod Pathol 15:
182A-183A.
2473. Srigley JR, Hutter RV, Gelb AB,
Henson DE, Kenney G, King BF, Raziuddin
S, Pisansky TM (1997). Current prognostic
factors—renal cell carcinoma:
Workgroup No. 4. Union Internationale
Contre le Cancer (UICC) and the American
Joint Committee on Cancer (AJCC).
Cancer 80: 994-996.
2474. Srinivas V, Herr HW, Hajdu EO
(1985). Partial nephrectomy for a renal
oncocytoma associated with tuberous
sclerosis. J Urol 133: 263-265.
2475. Sriplakich S, Jahnson S, Karlsson
MG (1999). Epidermal growth factor
receptor expression: predictive value for
the outcome after cystectomy for bladder
cancer? BJU Int 83: 498-503.
2476. Stadler WM, Steinberg G, Yang X,
Hagos F, Turner C, Olopade OI (2001).
Alterations of the 9p21 and 9q33 chromosomal
bands in clinical bladder cancer
specimens by fluorescence in situ
hybridization. Clin Cancer Res 7: 1676-
1682.
2477. Stallone G, Infante B, Manno C,
Campobasso N, Pannarale G, Schena FP
(2000). Primary renal lymphoma does
exist: case report and review of the literature.
J Nephrol 13: 367-372.
2478. Stamey TA, Johnstone IM, McNeal
JE, Lu AY, Yemoto CM (2002).
Preoperative serum prostate specific
antigen levels between 2 and 22 ng/ml
correlate poorly with post-radical prostatectomy
cancer morphology: prostate
specific antigen cure rates appear constant
between 2 and 9 ng/ml. J Urol 167:
103-111.
2479. Stamey TA, McNeal JE, Yemoto CM,
Sigal BM, Johnstone IM (1999). Biological
determinants of cancer progression in men
with prostate cancer. JAMA 281: 1395-
1400.
2480. Stamey TA, Villers AA, McNeal JE,
Link PC, Freiha FS (1990). Positive surgical
margins at radical prostatectomy: importance
of the apical dissection. J Urol 143:
1166-1172.
2481. Stamey TA, Warrington JA, Caldwell
MC, Chen Z, Fan Z, Mahadevappa M,
McNeal JE, Nolley R, Zhang Z (2001).
Molecular genetic profiling of Gleason
grade 4/5 prostate cancers compared to
benign prostatic hyperplasia. J Urol 166:
2171-2177.
2482. Stamp IM, Barlebo H, Rix M,
Jacobsen GK (1993). Intratubular germ cell
neoplasia in an infantile testis with immature
teratoma. Histopathology 22: 69-72.
2483. Stamp IM, Jacobsen GK (1995). Infant
intratubular germ cell neoplasia. Am J Surg
Pathol 19: 489.
2484. Stampfer DS, Carpinito GA,
Rodriguez-Villanueva J, Willsey LW,
Dinney CP, Grossman HB, Fritsche HA,
McDougal WS (1998). Evaluation of NMP22
in the detection of transitional cell carcinoma
of the bladder. J Urol 159: 394-398.
2485. Stanfield BL, Grimes MM, Kay S
(1994). Primary carcinoid tumor of the bladder
arising beneath an inverted papilloma.
Arch Pathol Lab Med 118: 666-667.
2486. Stanisic TH, Donovan J (1986).
Prolactin secreting renal cell carcinoma. J
Urol 136: 85-86.
2487. Stattin P, Bergh A, Karlberg L, Tavelin
B, Damber JE (1997). Long-term outcome of
conservative therapy in men presenting
with voiding symptoms and prostate cancer.
Eur Urol 32: 404-409.
2488. Stebbins CE, Kaelin WGJr, Pavletich
NP (1999). Structure of the VHL-ElonginC-
ElonginB complex: implications for VHL
tumor suppressor function. Science 284:
455-461.
2489. Steck PA, Pershouse MA, Jasser SA,
Yung WK, Lin H, Ligon AH, Langford LA,
Baumgard ML, Hattier T, Davis T, Frye C, Hu
R, Swedlund B, Teng DH, Tavtigian SV
(1997). Identification of a candidate tumour
suppressor gene, MMAC1, at chromosome
10q23.3 that is mutated in multiple
advanced cancers. Nat Genet 15: 356-362.
2490. Stefansson K, Wollmann RL (1982). S-
100 protein in granular cell tumors (granular
cell myoblastomas). Cancer 49: 1834-
1838.
2491. Steffens J, Girardot P, Bock R,
Braedel HU, Alloussi S, Ziegler M (1992).
[Carcinoma of the kidney with production of
renin. A special form of hypertension]. Ann
Urol (Paris) 26: 5-9.
2492. Steidl C, Simon R, Burger H,
Brinkschmidt C, Hertle L, Bocker W, Terpe
HJ (2002). Patterns of chromosomal aberrations
in urinary bladder tumours and adjacent
urothelium. J Pathol 198: 115-120.
2493. Stein BS, Kendall AR (1984).
Malignant melanoma of the genitourinary
tract. J Urol 132: 859-868.
2494. Stein BS, Rosen S, Kendall AR (1984).
The association of inverted papilloma and
transitional cell carcinoma of the urothelium.
J Urol 131: 751-752.
2495. Stein JP, Ginsberg DA, Grossfeld GD,
Chatterjee SJ, Esrig D, Dickinson MG,
Groshen S, Taylor CR, Jones PA, Skinner
DG, Cote RJ (1998). Effect of p21WAF1/CIP1
expression on tumor progression in bladder
cancer. J Natl Cancer Inst 90: 1072-1079.
2496. Stein JP, Grossfeld GD, Ginsberg
DA, Esrig D, Freeman JA, Figueroa AJ,
Skinner DG, Cote RJ (1998). Prognostic
markers in bladder cancer: a contemporary
review of the literature. J Urol 160:
645-659.
2497. Steinberg D (1975). Plasmacytoma of
the testis. Report of a case. Cancer 36:
1470-1472.
2498. Steinberg DM, Sauvageot J,
Piantadosi S, Epstein JI (1997). Correlation
of prostate needle biopsy and radical
prostatectomy Gleason grade in academic
and community settings. Am J Surg
Pathol 21: 566-576.
2499. Steinberg GD, Carter BS, Beaty TH,
Childs B, Walsh PC (1990). Family history
and the risk of prostate cancer. Prostate
17: 337-347.
2500. Steinberg GD, Epstein JI, Piantadosi
S, Walsh PC (1990). Management of stage
D1 adenocarcinoma of the prostate: the
Johns Hopkins experience 1974 to 1987. J
Urol 144: 1425-1432.
2501. Steiner G, Cairns P, Polascik TJ,
Marshall FF, Epstein JI, Sidransky D,
Schoenberg M (1996). High-density mapping
of chromosomal arm 1q in renal collecting
duct carcinoma: region of minimal
deletion at 1q32.1-32.2. Cancer Res 56:
5044-5046.
2502. Steiner M, Quinlan D, Goldman SM,
Millmond S, Hallowell MJ, Stutzman RE,
Korobkin M (1990). Leiomyoma of the kidney:
presentation of 4 new cases and the
role of computerized tomography. J Urol
143: 994-998.
2503. Steiner MS, Goldman SM, Fishman
EK, Marshall FF (1993). The natural history
of renal angiomyolipoma. J Urol 150: 1782-
1786.
2504. Stenman UH, Leinonen J, Alfthan H,
Rannikko S, Tuhkanen K, Alfthan O (1991).
A complex between prostate-specific
antigen and alpha 1-antichymotrypsin is
the major form of prostate-specific antigen
in serum of patients with prostatic
cancer: assay of the complex improves
clinical sensitivity for cancer. Cancer Res
51: 222-226.
2505. Stenram U, Holby LE (1969). A case
of circumscribed myosarcoma of the
prostate. Cancer 24: 803-806.
2506. Stephan C, Lein M, Jung K, Schnorr
D, Loening SA (1997). The influence of
prostate volume on the ratio of free to
total prostate specific antigen in serum of
patients with prostate carcinoma and
benign prostate hyperplasia. Cancer 79:
104-109.
2507. Stern RS (1990). Genital tumors
among men with psoriasis exposed to
psoralens and ultraviolet A radiation
(PUVA) and ultraviolet B radiation. The
Photochemotherapy Follow-up Study. N
Engl J Med 322: 1093-1097.
2508. Stewart AL, Grieve RJ, Banerjee SS
(1985). Primary lymphoma of the penis. Eur
J Surg Oncol 11: 179-181.
2509. Steyerberg EW, Keizer HJ, Stoter G,
Habbema JD (1994). Predictors of residual
mass histology following chemotherapy
for metastatic non-seminomatous testicular
cancer: a quantitative overview of 996
resections. Eur J Cancer 30A: 1231-1239.
2510. Stolle C, Glenn G, Zbar B, Humphrey
JS, Choyke P, Walther M, Pack S, Hurley
K, Andrey C, Klausner R, Linehan WM
(1998). Improved detection of germline
mutations in the von Hippel-Lindau disease
tumor suppressor gene. Hum Mutat
12: 417-423.
344 References